Mark W. Womack work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Mark W. Womack personal email
An organization builder with a track record of delivering unprecedented growth and profit in every role; An inspiring visionary and expert strategist with the uncompromising commitment and endless energy to back it up; A motivator, talent developer and creator of high-performance culture. Mark W. Womack is BioCina’s Chief Executive Officer, and in his first 9 months at the helm he led BioCina to a 500% YOY increase in sales and a 250% YOY increase in revenue. On February 1, 2024, he was also appointed to the Board of Directors for both NovaCina and LumaCina. Prior to BioCina, as CEO of KBI Biopharma and Selexis SA, Mr. Womack led the company to a run rate of over a 30% YOY revenue increase in only 6 months. Previous to that, as CEO and Managing Director of Stelis Biopharma, he led Stelis to build and qualify a state-of-the-art vaccine facility in record time, while also generating over $200M in new sales. Preceding Stelis, as the CBO for AGC Biologics, one of the world's leading global biopharma CDMO's, Mr. Womack led the organization to nearly a 300% increase in new sales in just two years. Over these two years, he drove the acquisition of many of the top Large Pharma companies into the AGC Biologics Client portfolio. Prior to joining AGC Biologics, Mr. Womack served over 20 years as a management consulting industry leader and C-level client advisor, guiding many of the world's renowned companies to achieve record highs in revenue and profit. He joined the management consulting industry with Capgemini as a Principal and within three years became a leader of large-scale transformations, including a $20B post-merger integration within General Motors. In 2001, Mr. Womack became EVP, Head of Consulting Operations—Americas, for Celerant Consulting. He led the organization to deliver client benefits of as much as over $100M per engagement and all-time highs in top and bottom-line growth for Celerant. In 2003, he founded his own boutique executive management consultancy, J.W. Webb Inc. For 11 years, J.W. Webb served elite clients such as Bayer HealthCare, CMC Biologics, Coors Brewing Company, and Whirlpool. Mr. Womack began his professional journey by leading a succession of U.S. Navy units to unprecedented results, including while serving as a combat center leader on a destroyer class ship. During his military career, he was honored with numerous of the Navy’s highest honors and awards. Mr. Womack has been quoted as a key source in The New York Times, Fast Company and many other major global media outlets.
-
Chief Executive OfficerBiocinaAustralia -
Member Of Board Of Directors For Novacina And LumacinaNovacina Feb 2024 - PresentBentley, Western Australia, Au -
Chief Executive OfficerBiocina Mar 2023 - PresentThebarton, South Australia, AuBioCina is a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), specializing in the development, and clinical and commercial manufacturing of the microbial, pDNA, and mRNA modalities. BioCina’s first facility in Adelaide, South Australia has a rich history of developing and manufacturing both clinical and commercial drug substance, backed by most critical SME’s having an average tenure of 15+ years at the site. BioCina boasts an elite quality record, having successfully passed regulatory inspections by the USFDA, Health Canada and EMA, and is licensed by the Australian TGA for cGMP manufacturing of bulk drug substance or active intermediates, and through it's partnership with NovaCina, BioCina is also able to offer its clients a highest-quality fill-and-finish solution.BioCina proudly serves clients based in the U.S., Europe and the Asia Pacific, and because they are not a drug developer, they only serve their client’s products. Furthermore, BioCina will be establishing a second large-scale, high-capacity end-to-end mammalian and microbial facility in Australia, to be ready for client service in 2026.In addition, Australia offers one of the most attractive R&D tax incentives available globally (up to 48.5% cash refund), making it an ideal destination for biologics companies looking to invest in research and development. -
Chief Executive OfficerKbi Biopharma May 2022 - Nov 2022Durham, North Carolina, UsKBI Biopharma is a leading global Biologics CDMO specializing in process development, analytical development and manufacturing, and Selexis SA is an industry-leading mammalian cell line development providerResponsible for the strategic vision, continued growth, and organizational culture of both organizations, including eight facilities in Europe and the USLed the company to a run rate of over a 30% YOY revenue increase in only 6 months, and implemented a new commercial strategy to generate significantly greater client program size and profitability -
Chief Executive Officer And Managing DirectorStelis Biopharma Aug 2021 - Feb 2022Bangalore, Karnataka, InP&L responsible for Stelis’ growth and overall development as a pure-play global biologics CDMOLed the generation of over $200M in contracted new salesOversaw the build and qualification of a state-of-the-art vaccine facility for both DS and DP in record time, as well as the successful production of the only 2K viral vector batches of the Sputnik Light vaccine in the worldLed the development and implementation of the infrastructure for a world class pure-play CDMO and the generation of a robust business development pipeline for its three facilities and end-to-end biologics CDMO offering, in only 6 months -
Chief Business OfficerAgc Biologics Jan 2019 - Aug 2021Bothell, Wa, UsMember of the AGC Biologics Global Executive Team, P&L responsible for leading, developing and growing one of the biopharmaceutical industry's global leadersAppointed by the Board to the role of Chief Business Officer, starting on Jan 1, 2019; Increased new business sales by 58% in 2019 and by 96% in 2020, exceeding the company’s 2020 sales target by EUR 177MLed the company's global Business Development and Marketing functions, with three Regional Sales Teams in North America, Europe and Asia, a global BD Operations Team and a global Marketing TeamLed the development and implementation of a global sales and marketing strategy and organization for Cell and Gene Therapy, following the acquisition of Molmed (in Milan, Italy) in 2020Drove the decision to acquire a large scale stainless steel mammalian facility in the US in 2020 and led the acquisition of a 600,000 sq. ft. gene therapy facility in 2021Led the development and implementation of a strategic approach to Large Pharma account acquisition, which led to far exceeding the company’s Large Pharma acquisition targets over the past two years -
Senior Vice President, Integration Management And Business ExcellenceAgc Biologics Feb 2018 - Dec 2018Bothell, Wa, UsMember of Global Executive Leadership TeamLed the development of the brand strategy for the newly formed company and then led the global integration of the three former CDMO’s that were merged to create AGC Biologics, in the US, Europe and Asia Led all company strategic initiatives -
Chief Operations OfficerParisella, Vincelli Associates Consulting Group, (Pva Consulting Group) Jul 2016 - Jan 2018Boisbriand, Quebec, CaGlobal management consulting firmResponsible for PVA’s growth and overall development of the business, included leading all aspects of PVA’s Business Development efforts, Client Assessment Engagements and Strategic Account Development across the Client Portfolio; In just 18 months, led a business turnaround and established the foundation for future growthLed an Executive Team comprised of 5 SVPs and 3 Directors of OperationsDesigned and installed a new Business Development approach, including significantly expanded US Business Development Territories, expansion of global Industry Sector Targets and a Strategic Account Development process -
Chief Operating OfficerBrooks International Jul 2014 - Jun 2016West Palm Beach, Fl, UsGlobal management consulting firmLed and developed all aspects of consulting sales and operations, staff and client engagements globally, including both Stage I Business Assessments and Stage II Business TransformationsLed the organization to achieve a 250% increase in annual revenue, including a 400% increase in client account extension and expansion and increased average engagement revenue by 200%Implemented Brooks International’s 2015 expansion into Asia and EuropeLed the delivery of over $300M CAD in bottom line cost savings for a leading liquids pipelines companyClient List spanned a wide range of industries in North America, Europe and Asia—including Enbridge, A. Schulman, Great West Life, TransCanada, Jack Cooper, The Boyd Group, Empire Life, The Triumph Group and Aventis -
Founder And PresidentJ.W. Webb, Inc. Mar 2003 - Jul 2014J.W. Webb, Inc. was a boutique leadership and management consulting services firm serving name brand clients globallyThe firm was founded in 2003, with a mission to guide executive leadership teams to define & execute a Leadership Blueprint™ for their organization and to accelerate and extend the development of leadersService areas included: Vision and strategy definition, strategy execution, top executive team and individual executive development, sales organization development, design and implementation of business performance management systems, organization design and implementation, organizational development and alignmentDesigned, implemented and led the Strategic Initiative Program for CMC Biologics from 2009-2014, which helped drive their tremendous development, growth and profit improvements; Partnered with the CEO to successfully drive improved performance from the Business Development and Marketing organizationDesigned and delivered the 2005 kick-off and launch of Safety-Kleen's restructured National Accounts and International Sales Organization; In the subsequent two quarters, the organization doubled its year-on-year growth rateClient List Included: Bayer HealthCare, Capgemini, CMC Biologics, Coors Brewing Co., Safety-Kleen, Whirlpool and Xerox
-
Executive Vice-President – Head Of Consulting Operations, AmericasCelerant Consulting Feb 1998 - Feb 2003London (Richmond-Upon-Thames), London, GbGlobal management consulting firmIn 2001, became Executive Vice President, Head of Consulting Operations, Americas—led the organization to a 32% annual revenue increase and 330% annual profit increaseP&L responsible; Led all aspects of client consulting services, with nine VP direct reports and 120+ consultantsLed the organization to deliver client benefits of as much as over $100 million per engagementIncreased average engagement revenue by 400%Led the development of a vision and strategic approach to the goals of a top executive team in Bayer’s Biological Products division; By following this blueprint, the organization realized a revenue increase ofover $80M and record-high profitAuthored, implemented and led the Organization Design, People Selection and Implementation service offering, which generated 15% of the Americas annual revenue within two yearsPrior to being promoted to Head of Consulting Operations, from 1999 thru 2000 generated the highest revenue in the Americas by 2x as a Senior Vice PresidentClient List Included: ARCO, Aventis, Bayer, Ford, Marathon Oil, Radio Shack, Shell and United Water -
PrincipalGemini Consulting & Services Jan 1994 - Jan 1998Saint Louis, Mo, UsGlobal management consulting firmService areas included: Organization design; post-merger integration, large-scale project design and delivery, achievement of engagement bottom-line financial targets, client account developmentLed the planning and execution of the $20B post-merger integration for GM’s Pontiac and GMC divisions— integrated all corporate functions, including the Sales and Service organizations for all Pontiac-GMC dealerships in the USLed the design and implementation of a new Sales and Service organization for Safety-Kleen, the leading industrial waste management and oil re-refining company in North America; Results included record highs in overall sales volume, including volume in targeted growth areasClient List Included: Oldsmobile, Pontiac-GMC and Safety-Kleen -
Organization Development And Training ConsultantOdt Consulting Jan 1992 - Jan 1994Design and delivery of training and development programs for client organizations; Program focus areas included leadership development and culture changeCo-designed and delivered the $60M Customer One culture change program that was lauded by periodicals such as the Wall Street Journal for its approach and impact; Overhead was cut by almost $5B in less than 4 years and the stock price quadrupled in 2 years; Was formally rated the top individual consultant by Chrysler participantsDeveloped and delivered the Ram Truck launch program for the U.S. Dodge Dealership Group; The program prepared dealer owners, management groups and sales personnel for the unprecedented market opportunity; Ram proceeded to set all-time Dodge records for truck market penetrationCo-designed and delivered a leadership development program for US Department of Agriculture senior executives; Program focused on mission and vision, leader effectiveness, team dynamics/effectiveness and coaching for success; Participants gave the program the highest possible ratingClient List Included: Chrysler, Dodge and U.S. Department of Agriculture
-
Multiple (Listed Below)Us Navy Dec 1979 - Dec 1991Washington, Dc, UsDirector of Training and Development, Fleet Training Center, San DiegoLead Instructor, Digital Weapons Systems Division, Fleet Training Center, San DiegoDivision Leader, Digital Weapons Systems Division, USS Fletcher (Destroyer Class)Small Craft Division Officer, USS PiedmontAwards included: Two Navy Achievement Medals for exceptional leadership, Instructor of the Year in the Pacific area (from over 350 instructors)
Mark W. Womack Skills
Mark W. Womack Education Details
-
Harvard Business SchoolLeading Professional Service Firms -
Chapman UniversityOrganization Development -
Southern Illinois University, CarbondaleEducation
Frequently Asked Questions about Mark W. Womack
What company does Mark W. Womack work for?
Mark W. Womack works for Biocina
What is Mark W. Womack's role at the current company?
Mark W. Womack's current role is Chief Executive Officer.
What is Mark W. Womack's email address?
Mark W. Womack's email address is m.****@****lis.com
What schools did Mark W. Womack attend?
Mark W. Womack attended Harvard Business School, Chapman University, Southern Illinois University, Carbondale.
What skills is Mark W. Womack known for?
Mark W. Womack has skills like Strategy, Leadership, Strategic Planning, Organizational Design, Management Consulting, Change Management, Leadership Development, Business Development, Organizational Development, Acquisition Integration, Business Process Improvement, Executive Coaching.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial